January 20, 2014

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2014 ACS

Patent Number: WO 2013176970
Title: Trka kinase inhibitors, compositions and methods thereof
Inventor(s): Stachel, Shawn J.; Egbertson, Melissa; Brnardic, Edward; Jones, Kristen; Sanders, John M.; Henze, Darrell A.
Patent Assignee(s): Merck Sharp & Dohme Corp., USA
Source: PCT Int. Appl., 77pp. CODEN: PIXXD2
Language: English

Abstract:
The present invention is directed to benzyl urea compds., which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence may be useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder assocd. with abnormal activities of nerve growth factor (NGF) receptor Trk-A, Trk-B and/or Trk-C.

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 View the full-text here.

Recent News

    August 21, 2016 | CAS announces SciFindern, a new
    research experience that elevates scientific discovery

    August 19, 2016 | CAS seeks to help undergraduate
    students think like researchers with Chemistry
    Class Advantage, an organic chemistry learning
    solution powered by SciFinder

    August 1, 2016 | CAS Strengthens its Commitment to
    Science and Innovation Selecting 26 Outstanding
    International Scientists to Participate in the 2016
    SciFinder Future Leaders Program

                                                                       More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org